Metabolic syndrome and its components predict all-cause and cardiovascular mortality in elderly: the Pro. V.A. study

被引:0
作者
Zanoni, S. [1 ]
Zambon, S. [1 ]
Romanato, G. [2 ]
Noale, M. [2 ]
Corti, M. C. [3 ]
Marin, R. [1 ]
Musachio, E. [1 ]
Sartori, L. [1 ]
Bagio, G. [3 ]
Crepaldi, G. [2 ]
Manzato, E. [1 ,2 ]
机构
[1] Univ Padua, Dipartimento Sci Med & Chirurg, Padua, Italy
[2] CNR, Ist Neurosci, Sez Invecchiamento, Padua, Italy
[3] Azienda Osped, Padua, Italy
关键词
Metabolic syndrome; All-cause mortality; Cardiovascular mortality;
D O I
暂无
中图分类号
学科分类号
摘要
Objectives. The objective of this study was to explore the association of metabolic syndrome and each of its components with all-cause and cardiovascular mortality in a general Italian elderly population. Methods. Metabolic syndrome, diagnosed by National Cholesterol Education Program Adult Treatment Panel III, all-cause and cardiovascular mortality were evaluated in 2910 subjects aged 65 years and older of the Progetto Veneto Anziani (Pro. V.A.) Study during a mean follow-up time of 4.4 years. Results. After multivariable adjustment, metabolic syndrome was associated with increased all-cause mortality in all subjects (HR = 1.41, 95% CI 1.16-1.72, p = 0.001), among men (HR = 1.42, 95% CI 1.06-1.89, p = 0.017), and women (HR = 1.47, 95% CI 1.13-1.91, p = 0.004). High glucose in all subjects and in women, and low HDL cholesterol in women were significant predictors of all-cause mortality, even independently from the interactions of different metabolic syndrome components. After multivariable adjustment, metabolic syndrome was also associated with increased cardiovascular mortality in all subjects (HR = 1.60, 95% CI 1.17-2.19, p = 0.003), among men (HR = 1.66, 95% CI 1.00-2.76, p = 0.051), and women (HR = 1.60, 95% CI 1.06-2.33, p = 0.025). High glucose and low HDL cholesterol among women predicted higher cardiovascular mortality. Conclusions. In this general Italian elderly population, among metabolic syndrome components all-cause mortality is better predicted by high glucose in all subjects and in women, and by low HDL cholesterol in women, while cardiovascular mortality is better predicted by high glucose, and low HDL cholesterol in women.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 50 条
  • [21] Associations of Cardiovascular and All-Cause Mortality with Metabolic Syndrome in Hemodialysis Patients: A Prospective Single-Center Study
    Dimitrijevic, Zorica
    Jovanovic, Andriana
    Cvetkovic, Mina
    Vrecic, Tamara
    Kostic, Emina
    Mitic, Branka
    MEDICINA-LITHUANIA, 2019, 55 (10):
  • [22] Cardiorespiratory Fitness and All-Cause Mortality in Women with Metabolic Syndrome
    Farrell, Stephen W.
    Leonard, David
    Shuval, Kerem
    Barlow, Carolyn E.
    DeFina, Laura F.
    Pavlovic, Andjelka
    Haskell, William L.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2023, 21 (03) : 148 - 155
  • [23] Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome
    Song, Xiaoying
    Xiong, Lijiao
    Guo, Tianting
    Chen, Xue
    Zhang, Pinjun
    Zhang, Xiaoan
    Liang, Zhen
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (11) : 2905 - 2919
  • [24] The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality
    Tsai, Shan Pou
    Wen, Chi Pang
    Chan, Hui Ting
    Chiang, Po Huang
    Tsai, Min Kuang
    Cheng, Ting Yuan David
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (01) : 148 - 156
  • [25] Is Prediction of Cardiovascular Disease and All-cause Mortality Genuinely Driven by the Metabolic Syndrome, and Independently from its Component Variables? The Dubbo Study
    Simons, Leon A.
    Simons, Judith
    Friedlander, Yechiel
    McCallum, John
    HEART LUNG AND CIRCULATION, 2011, 20 (04) : 214 - 219
  • [26] Association of Metabolic Syndrome With Long-Term Cardiovascular Risks and All-Cause Mortality in Elderly Patients With Obstructive Sleep Apnea
    Liu, Lin
    Su, Xiaofeng
    Zhao, Zhe
    Han, Jiming
    Li, Jianhua
    Xu, Weihao
    He, Zijun
    Gao, Yinghui
    Chen, Kaibing
    Zhao, Libo
    Gao, Yan
    Wang, Huanhuan
    Guo, JingJing
    Lin, Junling
    Li, Tianzhi
    Fang, Xiangqun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [27] Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients
    Protopsaltis, Ioannis
    Nikolopoulos, Georgios
    Dimou, Eftihia
    Brestas, Paris
    Kokkoris, Stelios
    Korantzopoulos, Panagiotis
    Melidonis, Andreas
    ATHEROSCLEROSIS, 2007, 195 (01) : 189 - 194
  • [28] Visit-to-visit variability in the measurements of metabolic syndrome components and the risk of all-cause mortality, cardiovascular disease, and arterial stiffness
    Wu, Mingyang
    Shu, Yanling
    Wang, Lulin
    Song, Lulu
    Chen, Shuohua
    Liu, Yunyun
    Bi, Jianing
    Li, Dankang
    Yang, Yingping
    Hu, Yonghua
    Sun, Yu
    Wang, Youjie
    Wu, Shouling
    Tian, Yaohua
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (10) : 2895 - 2903
  • [29] Impact of place of residence on the presentation of cardiovascular events and all-cause mortality in a cohort with metabolic syndrome
    Cabre Vila, Joan Josep
    Ortega Vila, Yolanda
    Aragones Benaiges, Enric
    Basora Gallisa, Josep
    Araujo Bernardo, Alvaro
    Sola Alberich, Rosa
    REVISTA ESPANOLA DE SALUD PUBLICA, 2018, 92
  • [30] The association between novel metabolic parameters and all-cause/cardiovascular mortality in patients with metabolic syndrome is modified by age
    Liu, Jiajun
    Fu, Yihui
    Liang, Pengpeng
    Song, Zhangxiao
    Li, Yue
    Wu, Hongyan
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)